Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  WuXi AppTec Co., Ltd.    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows:

- laboratory services (65,7%): small molecules discovery services, bioanalytical services, medical devices safety testing services, comprehensive manufacturing and testing services for cell and gene therapies, etc.;

- CMO and CDMO services (28.1%): development of manufacturing processes, production of advanced intermediates and active pharmaceutical ingredients, formulation development and dosage drug product manufacturing, for preclinical and clinical trials, new drug application, and commercial supply of chemical drugs, etc.;

- clinical research services (6.1%): project planning, clinical operation and monitoring and managements of phase I-IV clinical trials, medical device trials, etc.;

- other (0.1%).

Net sales are distributed geographically as follows: China (25.4%), Asia (2.9%), the United States (54.6%), Europe (15.8%) and other (1.3%) .

Number of employees : 21 744 people.
Sales per Business
20182019Delta
CNY (in Million)%CNY (in Million)%
Laboratory Services in China5,11353.3%6,47350.4% +26.59%
Small Molecule Drug Development Process and Production2,69928.2%3,75229.2% +39.02%
U.S. Laboratory Services1,20412.6%1,56312.2% +29.8%
Clinical Research and Other CRO Services584.636.1%1,0638.3% +81.79%
Other12.610.1%21.220.2% +68.26%
Sales per region
20182019Delta
CNY (in Million)%CNY (in Million)%
Foreign7,16974.8%9,90777.1% +38.19%
China2,43225.4%2,94422.9% +21.05%
Managers
NameAgeSinceTitle
Ge Li, Dr.532018Chairman, President & Co-Chief Executive Officer
Qing Yang502020Co-CEO, Executive Director & Executive VP
Harry He532016Chairman-Supervisory Board
Guo Dong Tong--Chief Operating Officer & Senior Vice President
Ellis Chu--Chief Financial Officer & Senior Vice President
Frederick H. Hausheer, Dr.-2019Chief Medical Officer
Edward Hu572020Vice Chairman & Chief Investment Officer
Ning Zhao, Dr.532016Executive Director & Vice President
Xiao Zhong Liu552016Director & Vice President
Zhao Hui Zhang502016Executive Director & Head-Government Affairs
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,135,096,445 1,149,418,094 53.8% 0 0.0% 47.1%
Stock B 0 306,924,384 0 0.0% 0 0.0%
Shareholders
NameEquities%
Summer Bloom Investments Pte Ltd. 145,124,379 8.44%
Boyu Capital Advisory Co. Ltd. 105,358,110 6.13%
New Wuxi Life Science Holdings Ltd. 100,535,130 5.84%
Jiashi Kangheng Tianjin Investment Enterprise LP 67,385,626 3.92%
Hillhouse Capital Management Ltd. /Invest/ 49,382,078 2.87%
China Universal Asset Management Co., Ltd. 44,943,313 2.61%
Ping An Insurance (Grp) Co of China Ltd 29,459,269 1.71%
Capital Research & Management Co. (World Investors) 28,972,700 1.68%
E Fund Management Co., Ltd. 23,848,423 1.39%
Ally Bridge Group HK Ltd 23,256,355 1.35%
Holdings
NameEquities%Valuation
Hygeia Healthcare Holdings Co., Limited (6078) 11,369,1801.84%59,852,025 USD
Sensorion (ALSEN) 4,192,1447.16%9,475,713 USD
Markets and indexes
-
- A-share
- SSE 50 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  603259.SH
- Datastream Code :  
Company contact information
WuXi AppTec Co., Ltd.
5 Bridge
CN-JS 214092 Wuxi


Phone : +86 (21) 5046-1111
Fax : +86 (21) 5046-1000
Internet : https://www.wuxiapptec.com/
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
WUXI APPTEC CO., LTD.56.01%34 473
GILEAD SCIENCES, INC.-4.20%78 044
VERTEX PHARMACEUTICALS20.18%68 537
REGENERON PHARMACEUTICALS48.47%58 662
BEIGENE, LTD.66.85%25 001
GENMAB A/S52.14%23 029
BIONTECH SE85.45%14 964
HUALAN BIOLOGICAL ENGINEERING INC.103.23%14 459
ARGENX SE45.96%11 501
SAREPTA THERAPEUTICS, INC.6.76%10 815
NEUROCRINE BIOSCIENCES, INC.-8.03%9 219
ASCENDIS PHARMA A/S7.26%7 939
EXELIXIS, INC.31.90%7 181
MIRATI THERAPEUTICS, INC.24.97%7 172
MYOKARDIA, INC.78.39%6 891
ZAI LAB LIMITED85.43%6 590
BIOCON LIMITED39.00%6 548
ACCELERON PHARMA INC.98.10%6 291
PEPTIDREAM INC.-20.18%5 130
ULTRAGENYX PHARMACEUTICAL INC.87.33%4 848
ARROWHEAD PHARMACEUTICALS, INC.-30.14%4 533